RxElite Company Top Insiders

RXEI Stock  USD 0.0001  0.00  0.00%   
Assessment of RxElite's management performance can provide insight into the firm performance.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RxElite. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in median.
For more detail on how to invest in RxElite Stock please use our How to Invest in RxElite guide.

RxElite Management Team Effectiveness

The company has return on total asset (ROA) of (0.3783) % which means that it has lost $0.3783 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.9354) %, meaning that it created substantial loss on money invested by shareholders. RxElite's management efficiency ratios could be used to measure how well RxElite manages its routine affairs as well as how well it operates its assets and liabilities.
Some institutional investors establish a significant position in stocks such as RxElite in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of RxElite, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

RxElite Workforce Comparison

RxElite is currently regarded as top stock in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 344. RxElite retains roughly 47.0 in number of employees claiming about 14% of equities under Health Care industry.
The company has Profit Margin (PM) of (2.8) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.97) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.97.

RxElite Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific RxElite insiders, such as employees or executives, is commonly permitted as long as it does not rely on RxElite's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, RxElite insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

RxElite Stakeholder

Richard TenerVice AdministrationProfile
String symbol = request.getParameter("s");

About RxElite Management Performance

The success or failure of an entity such as RxElite often depends on how effective the management is. RxElite management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of RxElite management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the RxElite management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
RxElite, Inc. engages in the development, manufacture, and marketing of generic prescription drug products in specialty generic markets. RxElite Inc. operates as a subsidiary of Piramal Healthcare Ltd. Rxelite operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 47 people.

RxElite Workforce Analysis

Traditionally, organizations such as RxElite use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare RxElite within its industry.

RxElite Manpower Efficiency

Return on RxElite Manpower

Revenue Per Employee59.8K
Net Loss Per Employee365.2K

Complementary Tools for RxElite Stock analysis

When running RxElite's price analysis, check to measure RxElite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RxElite is operating at the current time. Most of RxElite's value examination focuses on studying past and present price action to predict the probability of RxElite's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RxElite's price. Additionally, you may evaluate how the addition of RxElite to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital